"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...

The immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...

Sun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...

The United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...

The recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...

Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...

Donald Trump announced a forthcoming "major" tariff on pharmaceutical imports, aiming to incentivize drug companies to relocate operations ...

US tariffs on pharmaceutical imports will affect India’s pharma sector, a leader in affordable generics. Analyst Vishal Manchanda highlight...

Indian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales outpaced the impact of government p...

Indian companies are the main supplier of generic drugs to the world and procure almost 70% of the active pharmaceutical ingredients (APIs)...

Generic drugmakers are not meant to change their product labels until the innovator drug firm updates safety warnings on the label of its c...

The case is considered to have wide implications on public health and local drug industry.

Multinationals may have to move buyout proposals through FIPB, allowing the govt to understand the firm's rationale for buying a local firm.

NPPA has slashed the price of anti-asthma bulk drug used in popular brands such as Cipla's Asthalin, by 18% to Rs 3,633 per kg.

The government may levy duty on two important drug ingredients imported from China and Mexico to protect local suppliers.

The commerce, health and chemicals ministries have rejected global drugmakers controversial proposal to change key provisions of Indian pat...

German drug co recalled two batches of cancer drug made by its Indian arm on cross-contamination.